Block and modified gating of cardiac calcium channel currents by terodiline

Terodiline, an anticholinergic/antispasmodic drug effective in the treatment of urinary incontinence, is presently restricted due to adverse side effects on cardiac function. To characterize its effects on cardiac L‐type Ca2+‐channel current carried by Ca2+ (ICa,L) and Ba2+ (IBa,L), concentrations r...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 1999-08, Vol.127 (8), p.1837-1845
Main Authors: Ogura, Toshitsugu, Jones, Stephen, Shuba, Lesya M, McCullough, John R, McDonald, Terence F
Format: Article
Language:English
Subjects:
Animals
Biological and medical sciences
Butylamines - pharmacology
Calcium Channel Blockers - pharmacology
Calcium Channels - drug effects
Calcium Channels - physiology
Cardiovascular system
Drug toxicity and drugs side effects treatment
enhanced inactivation
Guinea Pigs
guinea‐pig ventricular myocytes
L‐type Ba2+ current (IBa,L)
L‐type Ca2+ current (ICa,L)
Medical sciences
Membrane Potentials - drug effects
Myocardium - cytology
Pharmacology. Drug treatments
Terodiline
Toxicity: cardiovascular system
use‐dependent block
Vasodilator agents. Cerebral vasodilators
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Terodiline, an anticholinergic/antispasmodic drug effective in the treatment of urinary incontinence, is presently restricted due to adverse side effects on cardiac function. To characterize its effects on cardiac L‐type Ca2+‐channel current carried by Ca2+ (ICa,L) and Ba2+ (IBa,L), concentrations ranging from 0.1 to 100 μM were applied to whole‐cell‐configured guinea‐pig ventricular myocytes. Although sub‐micromolar concentrations of terodiline had no effect on ICa,L at 0 mV, 100 μM drug reduced its amplitude to ca. 10% of pre‐drug control. The estimated IC50 (15.2 μM in K+‐dialysed cells, 12.2 μM in Cs+‐dialysed cells; 0.1 Hz pulsing rate) is eight times higher than reported for ICa,L in bladder smooth muscle myocytes. Terodiline affected ICa,L in a use‐dependent manner; block increased when the pulsing rate was increased from 0.1 to 2–3 Hz, and when holding potential was lowered from −43 mV. The drug accelerated the decay of ICa,L at 0 mV in a concentration‐dependent manner, and slowed the recovery of channels from inactivation. Terodiline reduced peak IBa,L more effectively than peak ICa,L, and markedly accelerated the rate of inactivation of the current. The results are discussed in terms of mechanisms of Ca2+ channel block and relation to the therapeutic and cardiotoxic effects of the drug. British Journal of Pharmacology (1999) 127, 1837–1845; doi:10.1038/sj.bjp.0702713
ISSN:0007-1188
1476-5381
DOI:10.1038/sj.bjp.0702713